MSS at Getinge Annual Partners Meeting 2025!

At the #SIRS2025, Med Surg Solutions reinforced its commitment to advancing vascular care through precision, innovation, and hands-on expertise.

MSS Strategic Partnership with W. L. Gore & Associates to Introduce Innovative Solutions

Med Surg Solutions is proud to introduce the GORE TAG Thoracic Branch Endoprosthesis—the first endovascular graft to be granted both FDA, SFDA and MDR CE mark approval, setting a new benchmark in aortic arch disease treatment.

Traditionally, treating aortic arch disease has been complex and high-risk. This single-device system simplifies Zone 2 revascularization, eliminating the need for surgical LSA debranching, significantly reducing procedural risks, and improving patient safety and efficiency.

Backed by 25+ years of thoracic aortic innovation, this device is designed for long-term durability, combining the conformability of the GORE TAG Conformable Device with the ability to endovascularly perfuse the left subclavian artery (LSA).

With Med Surg Solutions, the future of aortic repair is here—safer, more effective, and redefining patient outcomes.

4 Days. 3 Cities. 1 Vision.

Med Surg Solutions’ Kick-Off Meeting 2025 brought together teams across KSA and the GCC region, Dammam, Jeddah, and Riyadh, uniting expertise, strategy, and innovation to reshape the future of healthcare.

From milestone reflections to strategic breakthroughs, our leadership set the course for lifelong support, patient-driven solutions, and next-generation medical excellence.

Together, we move forward—driving progress, redefining patient outcomes, and shaping a healthier tomorrow.

Celebrating the United Nations International Women and Girls in Science Day.

Together, we fight..
Together, we heal..
Together, we stand.

Step into a day in the life of an MSS marketer — MSS’ innovation and life-long support.

And a journey from Beirut to Riyadh!

From groundbreaking advancements to hands-on innovation, the 3rd Riyadh Structural Heart Symposium 2025 brought together global healthcare experts to redefine the future of structural heart care.

The Minimally Invasive Organ Transplantation Consensus Conference (MIOT.CC - Riyadh) brought together global experts to redefine the future of organ transplantation. MSS played a pivotal role in making this landmark event a success, showcasing our holistic approach to enhancing the patient journey—from preventive medicine to advanced medical procedures and post-care solutions.

Aligned with Saudi Arabia’s Vision 2030 and its focus on quality healthcare, MSS remains committed to driving innovation and elevating standards of care. Our tailored solutions not only support the Saudi surgical community but also advance minimally invasive techniques that set global benchmarks.

MSS has been at the forefront of organ transplantation in Saudi Arabia, standing as a proud supporter since the very first successful liver transplant surgery and minimally invasive kidney transplant surgery in the kingdom. Today, we collaborate with leading global companies to develop innovative instruments tailored for minimally invasive procedures. Our dedicated Research and Business Development Department continually explores cutting-edge technologies to transform patient care and surgical outcomes.

With Saudi Arabia leading the world in organ transplantation, we are honored to contribute to shaping the future of healthcare innovation.